Dihexa 10mg Capsules Cognitive Research Support Peptide Pure Bio Labs Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are